GeneDx Holdings Corp. Annual Selling and Marketing Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
GeneDx Holdings Corp. quarterly/annual Selling and Marketing Expense history and growth rate from 2019 to 2023.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the quarter ending June 30, 2024 was $16.6M, a 9.24% increase year-over-year.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $65M, a 29.6% decline year-over-year.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2023 was $61M, a 50.1% decline from 2022.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2022 was $122M, a 8.28% increase from 2021.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2021 was $113M, a 78.4% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $61M -$61.1M -50.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 $122M +$9.34M +8.28% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $113M +$49.6M +78.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $63.2M +$23.8M +60.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $39.4M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.